Oesophageal Cancer Trial, Recruiting NCT00288119 Sponsor: Case Western Reserve University Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Oesophageal Cancer Trial, Recruiting

NCT00288119
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Barrett's esophagus (a condition affecting the lining of the food pipe), confirmed by previous test results and scope examination reports.
  • People who have been diagnosed with adenocarcinoma of the esophagus (a type of cancer of the food pipe).
  • Family members of someone who has Barrett's esophagus or adenocarcinoma of the esophagus.
  • People aged 18 or older at the time of joining the trial.
  • People under 18 years of age at the time of joining, provided a parent or guardian gives their consent.
  • People aged 18 or older who are able to understand and agree to participate in the trial on their own behalf.

Who may not be able to join:

  • There are no specific exclusion criteria listed in the official trial description (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amitabh Chak, MD, University Hospitals Cleveland Medical Center, CWRU, Cleveland, OH

Phone: 216-844-5385

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Case Western Reserve University
Registry
ClinicalTrials.gov
Start date
1 October 2005
Est. completion
31 July 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Assay of DNA and RNA markers

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov